High Prevalence of Unmet Healthcare Need among People who use Illicit Drugs in a Canadian Setting with Publicly-Funded Interdisciplinary Primary Care Clinics
Abstract
Background
People who use illicit drugs (PWUD) experience significant barriers to healthcare. However, little is known about levels of attachment to primary care (defined as having a regular family doctor or clinic they feel comfortable with) and its association with unmet healthcare needs in this population. In a Canadian setting that features novel publicly-funded interdisciplinary primary care clinics, we sought to examine the prevalence and correlates (including attachment to primary care) of unmet healthcare needs among PWUD.
Methods
Data were derived from two prospective cohort studies of PWUD in Vancouver, Canada between December 2017 and November 2018. Multivariable logistic regression was used to identify factors associated with self-reported unmet healthcare needs among participants reporting any health issues.
Results
In total, 743 (83.6%) of 889 eligible participants reported attachment to primary care and 220 (24.7%) reported an unmet healthcare need. In multivariable analyses, attachment to primary care at an integrated care clinic (adjusted odds ratio [AOR] = 0.14; 95% Confidence Interval [CI]: 0.06–0.34) was negatively associated with an unmet healthcare need, while being treated poorly at a healthcare facility (AOR = 5.50; 95% CI: 3.59–8.60) and self-reported chronic pain (AOR = 2.00, 95% CI: 1.30–3.01) were positively associated with an unmet healthcare need.
Conclusion
Despite the high level of attachment to primary care, a quarter of our sample reported an unmet healthcare need. Our findings suggest that multi-level interventions are required to address the unmet need, including pain management and integrated care, to support PWUD with complex health needs.
Get full access to this article
View all access and purchase options for this article.
References
1. Walker ER, Pratt LA, Schoenborn CA, Druss BG. Excess mortality among people who report lifetime use of illegal drugs in the United States: a 20-year follow-up of a nationally representative survey. Drug Alcohol Depend. 2017;171:31–38.
2. Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: Office of the Surgeon General; 2016.
3. Chitwood D, McBride DC, Metsch LR, Comerford M, McCoy CB. A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users. Am Behav Sci. 1998;41(8):1107–1122.
4. McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789–804.
5. Centre for Addiction and Mental Health. Mental Health and Primary Care Policy Framework. https://www.camh.ca/-/media/files/pdfs—public-policy-submissions/primarycarepolicyframework_march2016-pdf. Published 2016.
6. Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102.
7. Saitz R, Daaleman TP. Now is the time to address substance use disorders in primary care. Ann Fam Med. 2017;15(4):306–308.
8. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715–1723.
9. Korownyk C, Perry D, Ton J, et al. Managing opioid use disorder in primary care. Can Fam Physician. 2019;65(5):321–330.,
10. McGovern MP, Xie H, Segal SR, Siembab L, Drake RE. Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat. 2006;31(3):267–275.
11. Parthasarathy S, Mertens J, Moore C, Weisner C. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–367.
12. Gordon AJ, Drexler K, Hawkins EJ, et al. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275–282.
13. Vancouver Coastal Health. The 2nd generation strategy. http://dtes.vch.ca/secondgenerationstrategy/. Published 2018.
14. Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the vancouver downtown eastside from 2001 to 2011. J Urban Health. 2013;90(3):559–573.
15. OECD. Universal health coverage and health outcomes. https://www.oecd.org/els/health-systems/Universal-Health-Coverage-and-Health-Outcomes-OECD-G7-Health-Ministerial-2016.pdf. Published 2016.
16. Substance Abuse and Mental Health Services Adminstration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health; 2018. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
17. Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet health care needs and hepatitis C infection among persons who inject drugs in denver and seattle. Prev Sci. 2015;16(2):330–340.
18. Stein MD, Friedmann P. Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance. Am J Addict. 2002;11(4):262–270.
19. McKnight C, Shumway M, Masson CL, et al. Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017;16(4):404–419.
20. van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
21. Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2–3):188–196.
22. Lim S, Harris TG, Nash D, Lennon MC, Thorpe LE. All-cause, drug-related, and hiv-related mortality risk by trajectories of jail incarceration and homelessness among adults in New York City. Am J Epidemiol. 2015;181(4):261–270.
23. Lambdin BH, Comfort M, Kral AH, Lorvick J. Accumulation of jail incarceration and hardship, health status, and unmet health care need among women who use drugs. Womens Health Issues. 2018;28(5):470–475.
24. Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–1221.
25. Olding M, Hayashi K, Pearce L, et al. Developing a patient-reported experience questionnaire with and for people who use drugs: a community engagement process in Vancouver's Downtown Eastside. Int J Drug Policy. 2018;59:16–23.
26. Wood E, Kerr T, Marshall BDL, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338(1):b1649–b1194.
27. Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in patient-reported outcomes: the NIH PROMIS® measures. EGEMS. 2013;1(1):1015.
28. Merskey H. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986;3:S1–S226.
29. Hayashi K, Milloy M-J, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.
30. Statistics Canada. Has a regular healthcare provider, by age group. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009616. Accessed February 28, 2020.
31. Neil B, Campbell L, Culbert L. A Thousand Dreams: Vancouver's Downtown Eastside and the Fight for Its Future. Vancouver, Canada: D&M; 2010.
32. Vancouver Coastal Health. New clinic and new model of care on the DTES. http://dtes.vch.ca/2018/01/22/new-clinic-and-new-model-of-care-on-dtes/. Published 2018. Accessed February 16, 2020.
33. McCreaddie M, Lyons I, Watt D, et al. Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J Clin Nurs. 2010;19(19–20):2730–2740.
34. Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482–488.
35. Lebovits AH, Florence I, Bathina R, Hunko V, Fox MT, Bramble CY. Pain knowledge and attitudes of healthcare providers: practice characteristic differences. Clin J Pain. 1997;13(3):237–243.
36. Baldacchino A, Gilchrist G, Fleming R, Bannister J. Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav. 2010;35(3):270–272.
37. Voon P, Callon C, Nguyen P, et al. Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug Alcohol Rev. 2015;34(2):221–228.
38. Fibbi M, Silva K, Johnson K, Langer D, Lankenau SE. Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med. 2012;13(8):1040–1048.
39. Brener L, von Hippel W, von Hippel C, Resnick I, Treloar C. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev. 2010;29(5):491–497.
40. Shekarchizadeh H, KhamiMR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral health of drug abusers: a review of health effects and care. Iran J Public Health. 2013;42(9):929–940. https://pubmed.ncbi.nlm.nih.gov/26060654.
41. Radloff LS, The CES. D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
42. Napper LE, Fisher DG, Johnson ME, Wood MM. The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350–354.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: October 1, 2021
Issue published: October 2021
Keywords
PubMed: 33270542
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in Substance Use & Addiction Journal.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 72
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 0
Crossref: 3
-
Characterizing the Use of Healthcare Access Supports Among People Who ...
-
Exploring Primary Healthcare Experiences and Interest in Mobile Techno...
-
Inability to contact opioid agonist therapy prescribers during the COV...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
AMERSA members can access this journal content using society membership credentials.
AMERSA members can access this journal content using society membership credentials.
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
